SARMs (selective androgen receptor modulators) are synthetic compounds designed to selectively bind to androgen receptors in numerous tissues of the body.On receptor binding, semaglutide boosts insulin secretion within a glucose-dependent way though concurrently suppressing glucagon release from pancreatic α-cells. These twin actions contribute to